Search

Your search keyword '"Jassem, E"' showing total 949 results

Search Constraints

Start Over You searched for: "Jassem, E" Remove constraint "Jassem, E" Search Limiters Full Text Remove constraint Search Limiters: Full Text
949 results on '"Jassem, E"'

Search Results

1. Comprehensive analyses of immune activity in COVID-19-vaccinated idiopathic pulmonary fibrosis patients.

2. Catamenial Pneumothorax-Still an Unveiled Disease.

3. Synthesis and sensing characterizations of nanostructured tin-doped Fe2O3 thin films.

4. Venom Immunotherapy Does Not Affect Survival of Patients with Malignant Tumor in Poland.

5. Ziritaxestat, a novel autotaxin inhibitor, and lung function in idiopathic pulmonary fibrosis

6. Rhinitis associated with asthma is distinct from rhinitis alone:The ARIA-MeDALL hypothesis

7. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis

8. The ARIA-MeDALL hypothesis

10. Clinical Characteristics of EGPA Patients in Comparison to GPA Subgroup with Increased Blood Eosinophilia from POLVAS Registry.

11. Lipoid pneumonia induced by aspiration of liquid paraffin.

12. The influence of nutritional habits, body mass index and intestinal microbiota in mastocytosis on clinical symptoms using conventional culture and next generation sequencing.

13. Characteristics of Interstitial Pneumonia With Autoimmune Features (IPAF): Protocol for a Multicenter Prospective Study.

14. Is diet partly responsible for differences in COVID-19 death rates between and within countries?

15. Correlation between work impairment, scores of rhinitis severity and asthma using the MASK-air ® App

16. Polish Adaptation and Psychometric Validation of the PREM-C9 Questionnaire for Patients with Chronic Obstructive Pulmonary Disease.

17. Do guidelines influence breathlessness management in advanced lung diseases? A multinational survey of respiratory medicine and palliative care physicians

18. A Real-World Multicenter Retrospective Observational Study on Polish Experience with Nintedanib Therapy in Patients with Idiopathic Pulmonary Fibrosis: The PolExNIB Study.

19. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

20. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

21. Aligning the good practice mask with the objectives of the European innovation partnership on active and healthy ageing

22. Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA2LEN consensus

23. Value-Based Integrated Care (VBIC) Concept Implementation in a Real-World Setting-Problem-Based Analysis of Barriers and Challenges.

24. Development and validation of an electronic daily control score for asthma (e-DASTHMA): a real-world direct patient data study.

26. Digitally-enabled, patient-centred care in rhinitis and asthma multimorbidity: The ARIA-MASK-air ® approach.

27. Interacting with tumor cells weakens the intrinsic clockwise chirality of endothelial cells.

28. Correction to: Is diet partly responsible for differences in COVID-19 death rates between and within countries? (Clinical and Translational Allergy, (2020), 10, 1, (16), 10.1186/s13601-020-00323-0)

29. Aligning the good practice mask with the objectives of the European innovation partnership on active and healthy ageing

30. Correction to: Is diet partly responsible for differences in COVID-19 death rates between and within countries? (Clinical and Translational Allergy, (2020), 10, 1, (16), 10.1186/s13601-020-00323-0)

31. Adherence to treatment in allergic rhinitis using mobile technology. the mask study

32. ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

33. Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial

34. Guidelines of the Polish Respiratory Society on the Diagnosis and Treatment of Progressive Fibrosing Interstitial Lung Diseases Other than Idiopathic Pulmonary Fibrosis.

35. Comprehensive care for people living with heart failure and chronic obstructive pulmonary disease-Integration of palliative care with disease-specific care: From guidelines to practice.

36. Therapeutic decisions in a cohort of patients with idiopathic pulmonary fibrosis: a multicenter, prospective survey from Poland.

37. The role of the clinical and psychological symptoms of mastocytosis in the patient's quality of life.

38. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

39. End‑of‑life care for patients with advanced lung cancer and chronic obstructive pulmonary disease: Survey among Polish pulmonologists

40. Protocol of safe vaccination against COVID-19 in patients with high risk of allergic reactions.

41. miRNA profiles change during grass pollen immunotherapy irrespective of clinical outcome.

43. Benefits of Telemonitoring of Pulmonary Function-3-Month Follow-Up of Home Electronic Spirometry in Patients with Duchenne Muscular Dystrophy.

44. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018) : Change management in allergic rhinitis and asthma multimorbidity using mobile technology

45. Adherence to treatment in allergic rhinitis using mobile technology : The MASK Study

47. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

48. Mask 2017: Aria Digitally-Enabled, Integrated, Person-Centred Care For Rhinitis And Asthma Multimorbidity Using Real-World-Evidence

49. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

50. Do guidelines influence breathlessness management in advanced lung diseases? A multinational survey of respiratory medicine and palliative care physicians.

Catalog

Books, media, physical & digital resources